The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive- behavioral therapy or antidepressant medication for major depressive disorder
Open accessAbstract
OBJECTIVE: The purpose of this article was to inform the first-line treatment choice between cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive adults with major depressive disorder by defining a neuroimaging biomarker that differentially identifies the outcomes of remission and treatment failure to these interventions. METHOD: Functional MRI resting-state functional connectivity analyses using a bilateral subcallosal cingulate cortex (SCC) seed was applied to 122 patients from the Prediction of Remission to Individual and Combined Treatments (PReDICT) study who completed 12 weeks of randomized treatment with CBT or antidepressant medication. Of the 122 participants, 58 achieved remission (Hamilton Depression Rating Scale [HAM-D] score ≤7 at weeks 10 and 12), and 24 had treatment failure (<30% decrease from baseline in HAM-D score). A 2×2 analysis of variance using voxel-wise subsampling permutation tests compared the interaction of treatment and outcome. Receiver operating characteristic curves constructed using brain connectivity measures were used to determine possible classification rates for differential treatment outcomes. RESULTS: The resting-state functional connectivity of the following three regions with the SCC was differentially associated with outcomes of remission and treatment failure to CBT and antidepressant medication and survived application of the subsample permutation tests: the left anterior ventrolateral prefrontal cortex/insula, the dorsal midbrain, and the left ventromedial prefrontal cortex. Using the summed SCC functional connectivity scores for these three regions, overall classification rates of 72%-78% for remission and 75%-89% for treatment failure was demonstrated. Positive summed functional connectivity was associated with remission with CBT and treatment failure with medication, whereas negative summed functional connectivity scores were associated with remission to medication and treatment failure with CBT. CONCLUSIONS: Imaging-based depression subtypes defined using resting-state functional connectivity differentially identified an individual's probability of remission or treatment failure with first-line treatment options for major depression. This biomarker should be explored in future research through prospective testing and as a component of multivariate treatment prediction models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is possible that the subcallosal cingulate stimulation affects pathways that connect with the OFC (Johansen-Berg et al., 2008; Lujan et al., 2013; Dunlop et al., 2017; Riva-Posse et al., 2018).”
From The orbitofrontal cortex: reward, emotion and depression (2020) · cites this paper as Dunlop et al., 2017
Experimental — accuracy not yet measuredIn the citing paper
“Incorporation of gene-environment interactions improves the prediction of depression over the polygenic risk score approach. 302”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [302]
In the citing paper
“For example, a study of 122 treatment-resistant depression cases revealed two subtypes (53). One had negative sub- callosal cingulate cortex to left insula connectivity and responded to medication but not cognitive behavioral therapy. The other had positive connectivity and responded to therapy but not medication.”
From Methods and challenges for assessing heterogeneity (2020) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 1×
“Symptom severity using the HDRS, Hamilton Anxiety Rating Scale (43), and Beck Depression Inventory (44) was assessed weekly by blinded raters for the first 6 weeks after randomization and then every other week until week 12.”
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“Patients Adults aged 18–65 years were eligible to participate if they met DSM-IV criteria for a primary current diagnosis of nonpsychotic major depression as assessed by the Structured Clinical Interview for DSM-IV (40) and a psychiatrist’s evaluation, and if they scored $18 on the 17-item Hamilton DepressionRatingSca…”
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324 · cited 1×
“The SCC volume was defined using the Harvard-Oxford atlas (49), and the SCC was thresholded at 50% probability centered on MNI coordinates ±6, 24, −11 consistent with seeds used in our other studies of SCC (38,50).”
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 1×
“Symptom severity using the HAM-D, Hamilton Anxiety Rating Scale (43), and Beck Depression Inventory (44) was assessed weekly by blinded raters for the first 6 weeks after randomization and then every other week until week 12.”
The human brain is intrinsically organized into dynamic, anticorrelated functional networks
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504136102 · Cited by 8,553 · cited 1×
“The ventromedial portion of BA 10 in the prefrontal cortex is an important component of the default mode network (80) and is extensively connected to the SCC (via the fronto-medial extent of the uncinate fasciculus) (38), FIGURE 3.”
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L., & Petersen, S. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.018 · Cited by 7,429 · cited 1×
“Mean head motion of included subjects, assessed by framewise displacement (47), did not significantly differ between the treatment outcome groups.”
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Cognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Research works printed but not linked: 9
- Cuijpers P, Depress Anxiety
- Samson AC, 2011, J Psychiatr Res, 45, 1214
- Little JT, 1996, Psychopharmacol Bull, 32, 629
- Konarski JZ, 2009, J Psychiatry Neurosci, 34, 175
- First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0)
- Owens MJ, Dunlop BW, Plott S, et al: Poster presentation: Estimates of serotonin or norepinephrine transporter occupancy do not predict efficacy in a 12 week trial. Presented at the proceedings of the 54th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Fla, 2015
- 10.1016/j.jpsychires.2010.09.007 · DOI · Paper page
- 10.1016/j.biopsych.2008.04.033 · DOI · Paper page
- 10.1016/j.pscychresns.2008.09.004 · DOI
Cited by
Sorted by citations
Items 101–200 of 342
Nguyen, K. P., Fatt, C. C., Treacher, A., Mellema, C., Cooper, C. M., Jha, M. K., Kurian, B. T., D, M. F. M., McGrath, P. J., Weissman, M. M., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.09.011 · Cited by 28
Cakmak, J. D., Liu, L., Poirier, S. E., Schaefer, B., Poolacherla, R., Burhan, A. M., Sabesan, P., Lawrence, K. S., Théberge, J., Hicks, J. W., et al. (2022) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.210124 · Cited by 27
“The current study investigated these relationships in 4 parts using a hybrid approach of PET and MRI: (1) demonstrating aberrant microglial activity in the sgACC and insula in patients with MDD compared to healthy controls, (2) relating microglial activity to the observed severity of depression, (3) evaluating the fun…”
MethodBhattacharyya, S., Dunlop, B. W., MahmoudianDehkordi, S., Ahmed, A. T., Louie, G., Frye, M. A., Weinshilboum, R. M., Krishnan, R. R., Rush, A. J., Mayberg, H. S., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00926 · Cited by 27
Self-citationCBT and medication in depression (Review)
Vasile, C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9014 · Cited by 28
Hanuka, S., Olson, E. A., Admon, R., Webb, C. A., Killgore, W. D. S., Rauch, S. L., Rosso, I. M., & Pizzagalli, D. A. (2022) · Psychological Medicine · doi:10.1017/s0033291722001106 · Cited by 31
“…the sgACC is implicated in reward processing and anhedonia, as well as in treatment response in MDD (Alexander et al., 2019; Azab & Hayden, 2018; Dunlop et al., 2017; Gabbay et al., 2013; Guo, Hyett, Nguyen, Parker, & Breakspear, 2016; Nakamura et al., 2021; Narushima, McCormick, Yamada,…”
Fucich, E. A., Paredes, D., Saunders, M. O., & Morilak, D. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0635-17.2017 · Cited by 29
“They have suggested that different subtypes of depression may be associated with hyperactivity and hypoactivity of the vmPFC, the former responding to deep brain stimulation of the SCG, whereas the latter may respond to cognitive behavioral therapy (McGrath et al., 2013; Dunlop et al., 2017).”
BackgroundData-Driven Approaches to Neuroimaging Analysis to Enhance Psychiatric Diagnosis and Therapy
Zhang, X., Braun, U., Tost, H., & Bassett, D. S. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.015 · Cited by 31
Pantazatos, S. P., Yttredahl, A. A., Rubin‐Falcone, H., Kishon, R., Oquendo, M. A., Mann, J. J., & Miller, J. M. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.34 · Cited by 27
“In treatment-naïve participants with MDD, SCC rsFC differentially predicted the success of medication or CBT [19], highlighting a neural heterogeneity in the SCC in depression.”
BackgroundXiao, H., Yuan, M., Li, H., Li, S., Du, Y., Wang, M., Zhu, H., Zhang, W., Qiu, C., & Huang, X. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.013 · Cited by 25
Han, S., Cui, Q., Zheng, R., Li, S., Zhou, B., Fang, K., Sheng, W., Wen, B., Liu, L., Wei, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39861-z · Cited by 27
“Although these approaches show promise in practical clinical applications to a certain extent, such as informing treatment responses 13 and treatment selection 14 , they also have limitations.”
BackgroundLu, B., Chen, X., Castellanos, F. X., Thompson, P. M., Zuo, X., Zang, Y., & Yan, C. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.03.006 · Cited by 27
Fatt, C. C., Cooper, C. M., Jha, M. K., Aslan, S., Grannemann, B. D., Kurian, B. T., Greer, T. L., D, M. F. M., Weissman, M. M., McGrath, P. J., et al. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.06.019 · Cited by 26
Cuiping, X., Qi, L., Wang, X., Schaper, F. L. W. V. J., Wu, D., Yu, T., Yan, X., Jin, G., Wang, Q., Wang, X., et al. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.08.020 · Cited by 24
Aberrant impulse control circuitry in obesity
Barbosa, D. A. N., Kuijper, F. M., Duda, J., Wang, A. R., Cartmell, S. C. D., Saluja, S., Cunningham, T. N., Shivacharan, R. S., Bhati, M. T., Safer, D. L., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01640-5 · Cited by 24
“The NAc mask was defined on the standard MNI152 09c template adapted from CIT168 Subcortical In Vivo Probabilistic Atlas, while the vmPFC mask was defined using the Harvard-Oxford brain atlas, as used previously [31, 32].”
MethodNeuroimaging Advances for Depression.
Dunlop, B. W., & Mayberg, H. S. (2017) · Europe PMC (PubMed Central) · Cited by 23
Self-citationSSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
Preuss, A., Bolliger, B., Schicho, W., Hättenschwiler, J., Seifritz, E., Brühl, A. B., & Herwig, U. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.538393 · Cited by 22
“(41) showed higher connectivity between the subcallosal cingulum and various regions to predict treatment response to either antidepressant therapy or CBT, and several other studies showed the ACC as a treatment predictor for Behavioral Activation Therapy (42, 43).”
ResultÖzkan, B. N., Bozalı, K., Boylu, M. E., Velioğlu, H. A., Aktaş, S., Kırpınar, İ., & Güler, E. M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02942-8 · Cited by 24
“In psychotherapy, both treatments can be used support separately or in combination [4].”
BackgroundMetcalf, C. S., Huntsman, M., Garcia, G., Kochanski, A. K., Chikinda, M., Watanabe, E., Underwood, T. K., Vanegas, F., Smith, M. D., White, H. S., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00277 · Cited by 22
“Since antidepressants and psychotherapies have comparably low remission rates (30–40%) in patients with depression (140), delivering depression-related digital content (e.”
BackgroundEvaluation of the benefits of exercise on cognition in major depressive disorder
Greer, T. L., Furman, J. L., & Trivedi, M. H. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.06.002 · Cited by 21
Fu, C. H. Y., Erus, G., Yong Fan, A., Antoniades, M., Arnone, D., Arnott, S. R., Chen, T., Choi, K. S., Fatt, C. C., Frey, B. N., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04509-7 · Cited by 24
“MRI scans were acquired at baseline and week 12 [59, 60].”
BackgroundSelf-citationShu, Y., Wu, G., Bi, B., Liu, J., Xiong, J., & Kuang, L. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113612 · Cited by 20
Wade, B., Loureiro, J. R., Sahib, A. K., Kubicki, A., Joshi, S. H., Hellemann, G., Espinoza, R. T., Woods, R. P., Congdon, E. L., & Narr, K. L. (2022) · Psychological Medicine · doi:10.1017/s0033291722001313 · Cited by 19
“, 2011), cognitive behavioral therapy (Dunlop et al., 2017), transcranial magnetic stimulation (Fox, Buckner, White, Greicius, & Pascual-Leone, 2012; Salomons et al.”
BackgroundPrompiengchai, S., & Dunlop, K. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01907-1 · Cited by 23
Elias, G. J. B., Germann, J., Boutet, A., Beyn, M. E., Giacobbe, P., Song, H. N., Choi, K. S., Mayberg, H. S., Kennedy, S. H., & Lozano, A. M. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.08.014 · Cited by 20
“line with work that has utilized PET and resting state fMRI features to prognosticate the likelihood of response to cognitive behavioural therapy and antidepressant medication [104,105], it might be possible to derive robust neuroimaging biomarkers that could inform the decision to offer a patient DBS or to guide the…”
Self-citationBiomarker-Guided Tailored Therapy
Lydiard, J. B., & Nemeroff, C. B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_10 · Cited by 20
Self-citationReliability of fronto–amygdala coupling during emotional face processing
Nord, C., Gray, A., Robinson, O., & Roiser, J. (2019) · Brain Sciences · doi:10.3390/brainsci9040089 · Cited by 17
“Functional connectivity has been implicated as a possible ‘biomarker’ across a number of studies and treatment modalities, including pharmacological [5,6,37], psychological [8,37], and brain stimulation [38].”
BackgroundChen, Z., Huang, X., Gong, Q., & Biswal, B. B. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0798-1 · Cited by 17
Evaluating depression- and anxiety-like behaviors in non-human primates
Ausderau, K., Colman, R. J., Kabakov, S. A., SCHULTZ‐DARKEN, N. J., & Emborg, M. E. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1006065 · Cited by 17
“, 2018, 2019) and identified potential predictors of response to intervention (Konarski et al., 2009; Siegle et al., 2012; Dunlop et al., 2017), the neuroimaging findings still need to be sufficiently replicated to have robust clinical implications.”
BackgroundKlöbl, M., Gryglewski, G., Rischka, L., Godbersen, G. M., Unterholzner, J., Reed, M. B., Michenthaler, P., Vanicek, T., Pjrek, E., Hahn, A., et al. (2020) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2020.554186 · Cited by 17
Heinzel, S., Schwefel, M., Sánchez, A., Heinen, D., Fehm, L., Henze, R., Terán, C., Kallies, G., Rapp, M. A., Fydrich, T., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.024 · Cited by 16
Tang, G., Chen, P., Chen, G., Yang, Z., Ma, W., Yan, H., Su, T., Zhang, Y., Zhang, S., Qi, Z., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.035 · Cited by 16
A Clinician’s Guide to PTSD Biomarkers and Their Potential Future Use
Yang, S. M., Wynn, G. H., & Ursano, R. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20170045 · Cited by 16
Schneider, M. A., Spritzer, P. M., Minuzzi, L., Frey, B. N., Syan, S. K., Fighera, T. M., Schwarz, K., Costa, Â. B., da Silva, D. C., de Garcia, C. C. G., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00817 · Cited by 17
Interventional Psychiatry and Neurotechnologies: Education and Ethics Training
Giacobbe, P., Burhan, A. M., Waxman, R. E., & Ng, E. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.27 · Cited by 16
Mao, Y., Fan, L., Feng, C., & Dai, Z. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106120 · Cited by 15
Liu, X., Hou, Z., Yin, Y., Xie, C., Zhang, H., Zhang, H., Zhang, Z., & Yuan, Y. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.591407 · Cited by 14
“DMN is more active in the resting state, while in the task state, its activities is weakened (29).”
BackgroundUshio, K., Nakanishi, K., Mikami, Y., Yoshino, A., Takamura, M., Hirata, K., Akiyama, Y., Kimura, H., Okamoto, Y., & Adachi, N. (2020) · PubMed Central · doi:10.2147/jpr.s268529 · Cited by 14
“ventrolateral PFC and FP with the SCA was associated with remission and treatment failure.(43) Although we did”
MethodLawrence, A. J., Stahl, D. R., Duan, S., Fennema, D., Jaeckle, T., Young, A. H., Dazzan, P., Moll, J., & Zahn, R. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.06.010 · Cited by 20
Katayama, N., Nakagawa, A., Umeda, S., Terasawa, Y., Shinagawa, K., Kikuchi, T., Tabuchi, H., Abe, T., & Mimura, M. (2023) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2023.111643 · Cited by 17
Xu, C. D., Wang, S., Su, B., Ozuna, K., Mao, C., Dai, Z., & Wang, K. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.066 · Cited by 14
Song, E. J., Tozzi, L., & Williams, L. M. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.016 · Cited by 15
“In PReDICT, lower connectivity of the subcallosal cingulate with the insula and ventral frontal regions was associated with remission to escitalopram and treatment failure with cognitive behavioral therapy (55).”
Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review
Wojtalik, J. A., Eack, S. M., Smith, M. J., & Keshavan, M. S. (2018) · Journal of the Society for Social Work and Research · doi:10.1086/697566 · Cited by 17
“Finally, Dunlop et al. (2017) used multivariate pattern analysis to examine connectivity signatures of clients with major depression who responded to CBT and antidepressant medication compared to clients who were not responsive to treatment.”
MethodCircuit-Based Approaches to Understanding the Anterior Cingulate Cortex (ACC)
Myers, D. C., Simon, J. R., Oh, J., Kabotyanski, K. E., Fujimoto, S., Oathes, D., Rudebeck, P., Amemori, K., Sheth, S., & Fudge, J. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1311-25.2025 · Cited by 12
Thai, M., Olson, E. A., Nickels, S., Dillon, D. G., Webb, C. A., Ren, B., Killgore, W. D. S., Rauch, S. L., Rosso, I. M., & Pizzagalli, D. A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03020-9 · Cited by 13
Current pharmacotherapeutic approaches for dysthymic disorder and persistent depressive disorder
Carta, M. G., Paribello, P., Nardi, A. E., & Preti, A. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1637419 · Cited by 14
“Moreover, in MDD the connectivity between different brain areas under resting conditions has been shown to significantly predict response to first-line treatment, either psychotherapy or to medication [36].”
BackgroundLangenecker, S. A., Crane, N. A., Jenkins, L. M., Phan, K. L., & Klumpp, H. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0140-2 · Cited by 11
Langenecker, S. A., Klumpp, H., Peters, A. T., Crane, N. A., DelDonno, S. R., Bessette, K. L., Ajilore, O., Leow, A., Shankman, S. A., Walker, S. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.001 · Cited by 11
“…the role of intrinsic network connectivity (e.g., KeyNet) in the prediction of treatment response in mood and related disorders (Klumpp et al., 2014; Salomons et al., 2013; Dichter et al., 2015; Whitfield-Gabrieli et al., 2015; van Waarde et al., 2014; Ge et al., n.d.; Dunlop et al., 2017).”
Lueken, U., & Hahn, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00017-1 · Cited by 12
Ye, Y., Wang, C., Lan, X., Li, W., Fu, L., Zhang, F., Liu, H., Wu, K., Zhou, Y., & Ning, Y. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103230 · Cited by 12
Ahmed, R., Boyd, B. D., Elson, D. M., Albert, K. M., Begnoche, J. P., Kang, H., Landman, B. A., Szymkowicz, S. M., Andrews, P., Vega, J. N., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722003579 · Cited by 12
“Substantial work associates the response to anti-depressant medications and cognitive behavioral therapy with both sgACC activity (Konarski et al., 2009; Mayberg et al., 1997) and sgACC functional connectivity (Dunlop et al., 2017, 2019; Kozel et al., 2011).”
InfluentialStrege, M. V., Siegle, G. J., Richey, J. A., Krawczak, R. A., & Young, K. D. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00756-0 · Cited by 14
Kaneko, N., Wada, M., Nakajima, S., Takano, M., Taniguchi, K., Honda, S., Mimura, M., & Noda, Y. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhad515 · Cited by 13
What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
Fujimoto, S., Fujimoto, A., Elorette, C., Choi, K. S., Mayberg, H. S., Russ, B. E., & Rudebeck, P. H. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01976-2 · Cited by 13
Self-citationPrediction of individual patient outcomes to psychotherapy vs medication for major depression
LoParo, D., Dunlop, B. W., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00119-9 · Cited by 13
“…for several reasons: (a) the Youden index requires a dichotomous decisionvariable;(b)previousanalysesinthePReDICTstudyhavecombined medication groups 34 ; (c) a priori treatment decisions made by depressed individuals and practitioners are often between whether to begin treatment with psychotherapy…”
Self-citationBrain-Based Biomarkers for the Treatment of Depression: Evolution of an Idea
Waters, A. C., & Mayberg, H. S. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000881 · Cited by 13
“However, following the observation by Semonowicz et al. (2004) of different frontal lobe path models for responders to CBT or drug, a more explicit functional connectivity approach is now being explored (Dunlop et al., 2017; Fox, Buckner, White, Greicius, & Pascual-Leone, 2012).”
MethodSelf-citationDiffusion tensor imaging correlates of depressive symptoms in Parkinson disease
Uhr, L., Tsolaki, E. C., & Pouratian, N. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25310 · Cited by 12
“Such depression subtypes can be distinguished by functional connectivity differences within depression-related networks, which are associated with specific clinical symptom profiles (Drysdale et al., 2017) and treatment outcome (Dunlop et al., 2017).”
BackgroundCingulate-mediated depressive symptoms in neurologic disease and therapeutics
Riva‐Posse, P., Holtzheimer, P. E., & Mayberg, H. S. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64196-0.00021-2 · Cited by 14
Self-citationGetting Personalized: Brain Scan Biomarkers for Guiding Depression Interventions
Williams, L. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030314 · Cited by 12
Assessing in-session rumination and its effects on CBT for depression
Kennedy, J. C., Dunlop, B. W., Craighead, L. W., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104209 · Cited by 11
Self-citationZhang, J., Duan, J., Li, W., Wang, X., Ren, S., Ye, L., Liu, F., Tian, X., Xie, Y., Huang, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq0444 · Cited by 11
Application of Neuroimaging in the Diagnosis and Treatment of Depression
Arslan, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_5 · Cited by 11
Godlewska, B. R. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00198-2 · Cited by 15
Wang, C., Dyk, K. V., Cho, N. S., Raymond, C., Choi, J. J., Salamon, N., Pope, W. B., Lai, A., Cloughesy, T. F., Nghiemphu, P. L., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00497-6 · Cited by 10
Balancing the beautiful and the good in pursuit of biomarkers for depression
Mayberg, H. S., & Dunlop, B. W. (2023) · World Psychiatry · doi:10.1002/wps.21081 · Cited by 10
Self-citationPoggi, G., Klaus, F., & Pryce, C. R. (2024) · Brain Communications · doi:10.1093/braincomms/fcae140 · Cited by 11
“This is done firstly for in vivo studies and secondly for post-mortem/ex vivo studies.”
BackgroundConvergent neurobiological predictors of mood and anxiety symptoms and treatment response
Jabbi, M., & Nemeroff, C. B. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1620604 · Cited by 10
Self-citationYoung, M. E., Spencer-Salmon, C. A., Mosher, C. P., Tamang, S., Rajan, K., & Rudebeck, P. H. (2023) · Neuron · doi:10.1016/j.neuron.2023.07.012 · Cited by 10
McCarty, P. J., Pines, A. R., Sussman, B. L., Wyckoff, S. N., Jensen, A., Bunch, R., Boerwinkle, V. L., & Frye, R. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100969 · Cited by 10
“In patients with treatment-naïve MDD, rs-fMRI has been used to define biomarkers of depression subtypes and the differential response to various treatment modalities [28], which could greatly reduce the time and resources needed to identify the most appropriate and efficacious course of treatment.”
MethodBeckmann, F., Seidenbecher, S., Metzger, C. D., Gescher, D. M., Carballedo, A., Tozzi, L., O’Keane, V., & Frodl, T. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111440 · Cited by 10
Nakayama, R., Ikegaya, Y., & Sasaki, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-47171-y · Cited by 10
Solomonov, N., Victoria, L. W., Mir, Z., Phan, D. K., Hoptman, M. J., Areán, P. A., Alexopoulos, G. S., & Gunning, F. M. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.11.017 · Cited by 11
Liang, Q., Zhou, Z., Chen, S., Lin, S., Lin, X., Li, Y., Zhang, Y., Peng, B., Hou, G., & Qiu, Y. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03238-1 · Cited by 11
Gunatilake, N., Boyes, A., Elwyn, R., Brunet, A., Hermens, D. F., & Driver, C. (2025) · Adolescent Research Review · doi:10.1007/s40894-025-00263-5 · Cited by 13
Cha, J., Raj, D., Choi, K. S., Rajendra, J. K., Nemeroff, C. B., Felger, J. C., Craighead, W. E., Mayberg, H. S., & Dunlop, B. W. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.026 · Cited by 12
Self-citationPan, M., Zhao, M., Liu, L., Li, H., Wang, Y., & Qian, Q. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037514 · Cited by 12
Demyttenaere, K., Frank, E., Castle, D. J., & Cindik-Herbrüggen, E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01038-w · Cited by 9
“in the Prediction of Remission to Individual and Combined Treatments (PReDICT) study [25].”
BackgroundInfluentialBulubas, L., Padberg, F., Mezger, E., Suen, P. J. C., Bueno, P. V. S., Duran, F., Busatto, G. F., Amaro, E., Benseñor, I. M., Lotufo, P. A., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01187-y · Cited by 9
Daniela Calvetti, A., Johnson, B., Pascarella, A., Pitolli, F., Somersalo, E., & Vantaggi, B. (2021) · Brain Topography · doi:10.1007/s10548-021-00874-w · Cited by 11
Wallace, M. L., Banihashemi, L., O'Donnell, C. P., Nimgaonkar, V. L., Kodavali, C. V., McNamee, R. L., & Germain, A. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.07.051 · Cited by 9
Wei, D., Wang, K., Meng, J., Zhuang, K., Chen, Q., Yan, W., Xie, P., & Qiu, J. (2019) · Psychological Medicine · doi:10.1017/s0033291719000230 · Cited by 9
“Recently, a study indicated that the functional connectivity of SCR was significantly correlated with patient’s percent change in the HDRS by treatment (Dunlop et al., 2017).”
BackgroundFennema, D., Barker, G. J., O’Daly, O., Duan, S., Carr, E., Goldsmith, K., Young, A. H., Moll, J., & Zahn, R. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100308 · Cited by 8
“Interestingly, in Dunlop et al. (46), this direction of connectivity was associated with response to CBT — and failure to respond to antidepressant medications.”
InfluentialBhattacharyya, S., MahmoudianDehkordi, S., Sniatynski, M. J., Belenky, M., Marur, V. R., Rush, A. J., Craighead, W. E., Mayberg, H. S., Dunlop, B. W., Kristal, B. S., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.064 · Cited by 8
Self-citationDeveloping Clinically Interpretable Neuroimaging Biotypes in Psychiatry
Ahn, J., Foland‐Ross, L. C., Akiki, T. J., Boyar, L., Wydler, I., Bostian, C. M., Zhang, X., Yang, H., Ellsay, A., Ma, E. W., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.08.019 · Cited by 11
“…trial of never-treated MDD (63) identified lower affective circuit connectivity (left sgACC to insula, periaqueductal gray, and ventral PFC) as a differential predictor of remission with citalopram or duloxetine but failure with CBT, whereas higher connectivity predicted the opposite (64).”
Kang, Y., Jung, J., Han, K., Auer, D. P., & Ham, B. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120607 · Cited by 7
Li, F., Jörg, F., Merkx, M. J. M., & Feenstra, T. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.111 · Cited by 8
Wei, Y., Zhang, R., Wang, Y., Womer, F. Y., Dong, S., Zheng, J., Zhang, X., & Wang, F. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115542 · Cited by 9
Where to Target? The Precision Medicine Approach to Brain Stimulation
McMullen, D. P. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.010 · Cited by 8
Are substance use disorders emotional disorders? Why heterogeneity matters for treatment.
McHugh, R. K., & Goodman, F. R. (2019) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12286 · Cited by 8
Dhami, P., Quilty, L. C., Schwartzmann, B., Uher, R., Allen, T. A., Kloiber, S. M., Lam, R. W. M., MacQUEEN, G. M., Frey, B. N., Milev, R. V., et al. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100413 · Cited by 10
Zhou, Z., Zhang, L., Hu, X., Cao, L., Gao, Y., Li, H., Bao, W., Tang, M., Sun, H., Kuang, W., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03758-w · Cited by 7
“The ventral ACC, particularly its subgenual part, has emerged as the major target for network-based neuromodulation in depression [17 – 19], and its connectivity patterns have shown promise in predicting outcomes of antidepressant treatments [20, 21].”
Psychoradiological Biomarkers for Psychopharmaceutical Effects
Schrantee, A., Ruhé, H. G., & Reneman, L. (2019) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2019.09.006 · Cited by 8
Zarate‐Guerrero, S., Duran, J. M., & Naismith, I. (2022) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2704 · Cited by 11
Zhao, L., Wang, D., Xue, S., Tan, Z., Hong, L., Wang, Y., Li, H., Pan, C., Fu, S., Hu, X., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.771147 · Cited by 7
“For example, effective antidepressant treatment for MDD patients was relevant with lower functional connectivity (FC) between the subcallosal cingulate cortex and ventromedial prefrontal cortex (17).”
BackgroundZahn, R. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119423 · Cited by 8
Neuroimaging Advance in Depressive Disorder
Peng, D., & Yao, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_3 · Cited by 5
Feng, H., Wang, M., Zhao, H.-M., Hou, X., Xu, B., Gui, Q., Wu, G., Dong, X., Xu, Q., Shen, M.-Q., et al. (2022) · PubMed Central · Cited by 5
Ran, M., Zhang, H., Jin, M., Tao, Y., Xu, H., Zou, S., Wang, Z., Deng, F., Huang, L., Zhang, H., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1487754 · Cited by 5
Precision Psychiatry: Personalized Clinical Approach to Depression
Perna, G., Balletta, R., & Nemeroff, C. B. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_21 · Cited by 5
Self-citationRubart, A., Hohagen, F., & Zurowski, B. (2018) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-0598-4972 · Cited by 5
“Die funktionelle Konnektivität des subgenualen anterioren Cingulums mit dem linken ventrolateralen präfrontalen Kortex/ der linken Insula, dem linken ventromedialen präfrontalen Kortex und dem linken dorsalen Mittelhirn (Raphe-Kerne und periaquäduktales Grau) scheint ebenfalls differenziell mit Ansprechen auf Kognitiv…”
BackgroundRidderbusch, I. C., Richter, J., Yang, Y., Hoefler, M., Weber, H., Reif, A., Hamm, A. O., Pané‐Farré, C. A., Gerlach, A. L., Ströhle, A., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.133 · Cited by 5
Metadata
- Authors
- Dunlop, B. W., Rajendra, J. K., Craighead, W. E., Kelley, M. E., McGrath, C. L., Choi, K. S., Kinkead, B., Nemeroff, C. B., & Mayberg, H. S.
- Affiliations
- Harvard University (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2017-06-01
- Volume
- 174
- Issue
- 6
- Pages
- 533-545
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC5453828
- OpenAlex
- W2600118519
- Cited by
- 342
- References
- 80
- Citations by year
- 2026: 20 · 2025: 32 · 2024: 30 · 2023: 30 · 2022: 31 · 2021: 47 · 2020: 55 · 2019: 50 · 2018: 28 · 2017: 19
- FWCI
- 23.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01mh080880-05, UL1TR000454)
- National Institute of Mental Health (K23MH086690, R01-MH080880, P50MH077083)
- National Center for Research Resources (UL1RR025008, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, resting-state functional connectivity, cognitive behavioral therapy, antidepressants, treatment response prediction, remission, treatment failure, neuroimaging biomarkers, ventromedial prefrontal cortex, dorsal midbrain, anterior insula, ventrolateral prefrontal cortex, individualized treatment selection
- MeSH terms
- Duloxetine Hydrochloride, Adolescent, Adult, Aged, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Dominance, Cerebral, Female, Gyrus Cinguli, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Net, Psychiatric Status Rating Scales, Citalopram, Cognitive Behavioral Therapy, Outcome Assessment, Health Care, Prefrontal Cortex, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review